MyD88 signal is required for more efficient induction of Ag-specific adaptive immune responses and antitumor resistance in a human papillomavirus E7 DNA vaccine model (Q43939880)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	MyD88 signal is required for more efficient induction of Ag-specific adaptive immune responses and antitumor resistance in a human papillomavirus E7 DNA vaccine model	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

MyD88 signal is required for more efficient induction of Ag-specific adaptive immune responses and antitumor resistance in a human papillomavirus E7 DNA vaccine model (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

author name string

Jeong-Im Sin

1

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

language of work or name

0 references

publication date

13 April 2011

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

29

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

24

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

4125-4131

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Pathogen recognition and innate immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.098

7 January 2021

Recognition of microorganisms and activation of the immune response

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.098

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.098

7 January 2021

Toll-like receptor control of the adaptive immune responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.098

7 January 2021

Priming of CD8+ T-cell responses after DNA immunization is impaired in TLR9- and MyD88-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.098

7 January 2021

Control of B-cell responses by Toll-like receptors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.098

7 January 2021

Vaccination with plasmid DNA activates dendritic cells via Toll-like receptor 9 (TLR9) but functions in TLR9-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.098

7 January 2021

CD8 positive T cells influence antigen-specific immune responses through the expression of chemokines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.098

7 January 2021

Protective immunity against heterologous challenge with encephalomyocarditis virus by VP1 DNA vaccination: effect of coinjection with a granulocyte-macrophage colony stimulating factor gene

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.098

7 January 2021

Protective immune correlates can segregate by vaccine type in a murine herpes model system.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.098

7 January 2021

Both antigen optimization and lysosomal targeting are required for enhanced anti-tumour protective immunity in a human papillomavirus E7-expressing animal tumour model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.098

7 January 2021

Suppression of antitumour protective cytotoxic T lymphocyte responses to a human papillomavirus 16 E7 DNA vaccine by coinjection of interleukin-12 complementary DNA: involvement of nitric oxide in immune suppression

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.098

7 January 2021

Bacterial CpG DNA activates immune cells to signal infectious danger.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.098

7 January 2021

CpG motifs in bacterial DNA and their immune effects

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.098

7 January 2021

Immunostimulatory effects of plasmid DNA and synthetic oligodeoxynucleotides

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.098

7 January 2021

Immunostimulatory DNA sequences necessary for effective intradermal gene immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.098

7 January 2021

CpG motifs are efficient adjuvants for DNA cancer vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.098

7 January 2021

A Therapy Modality Using Recombinant IL-12 Adenovirus plus E7 Protein in a Human Papillomavirus 16 E6/E7-Associated Cervical Cancer Animal Model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.098

7 January 2021

CpG-ODN-stimulated dendritic cells act as a potent adjuvant for E7 protein delivery to induce antigen-specific antitumour immunity in a HPV 16 E7-associated animal tumour model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.098

7 January 2021

Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.098

7 January 2021

Antitumor therapeutic effects of e7 subunit and DNA vaccines in an animal cervical cancer model: antitumor efficacy of e7 therapeutic vaccines is dependent on tumor sizes, vaccine doses, and vaccine delivery routes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.098

7 January 2021

Increased sensitivity of radiated murine cervical cancer tumors to E7 subunit vaccine-driven CTL-mediated killing induces synergistic anti-tumor activity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.098

7 January 2021

Antitumor therapeutic and antimetastatic activity of electroporation-delivered human papillomavirus 16 E7 DNA vaccines: a possible mechanism for enhanced tumor control.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.098

7 January 2021

Signaling via the MyD88 adaptor protein in B cells suppresses protective immunity during Salmonella typhimurium infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.098

7 January 2021

Mice deficient in MyD88 Develop a Th2-dominant response and severe pathology in the upper genital tract following Chlamydia muridarum infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.098

7 January 2021

Myeloid differentiation factor 88 is required for cross-priming in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.098

7 January 2021

A Toll-like receptor recognizes bacterial DNA

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.098

7 January 2021

Immune cell activation by bacterial CpG-DNA through myeloid differentiation marker 88 and tumor necrosis factor receptor-associated factor (TRAF)6.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.098

7 January 2021

Regression of established human papillomavirus type 16 (HPV-16) immortalized tumors in vivo by vaccinia viruses expressing different forms of HPV-16 E7 correlates with enhanced CD8(+) T-cell responses that home to the tumor site

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.098

7 January 2021

Cancer immunotherapy using Sindbis virus replicon particles encoding a VP22-antigen fusion.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.098

7 January 2021

Endotoxin-induced maturation of MyD88-deficient dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.098

7 January 2021

Toll-like receptor adaptor molecules enhance DNA-raised adaptive immune responses against influenza and tumors through activation of innate immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.098

7 January 2021

Identifiers

10.1016/J.VACCINE.2011.03.098

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43939880&oldid=2104529891"